LOCATION EXCELLENT RESEARCH In Buch, doctors and researchers have been dedicating themselves to the future of medicine and human health for 100 years As a location for science and healthcare, Buch is one of Berlin‘s established centres for the future. Fundamental biomedical research is closely linked with clinical research in Buch, with the aim of bringing newly developed processes in diagnostics, treatment and prevention into use rapidly. Berlin-Buch enjoys an international reputation as an excellent location for science, medicine and technology, and – with its focuses on the healthcare sector, life science, biotechnology and medicine – it is one of the most significant players in the healthcare industries cluster in the capital city region. Decisive here are the Max Delbrück Center for Molecular Medicine (MDC), the Leibniz-Institut für Molekulare Pharmakologie (FMP) and the Experimental and Clinical Research Centre (ECRC), which is mutually run by the MDC and the Charité – Universitäts medizin Berlin. The facilities work closely together and form the basis for unique, patient-orientated fundamental research. With the Berlin Institute of Health (BIG), the MDC and Charité consolidate their experimental and clinical research under a holistic, systemic medical research approach. The aim is to gain a better understanding of diseases through new scientific and technol ogical approaches, and develop new diagnostic, treatment and prevention processes. Outstanding technologies are available for the research: Scientific platforms for genomics, proteomics, metabolomics, Ultra High-Field Magnetic Resonance Imaging, NMR spectroscopy and a screening unit for identifying active agents. many has established itself on the research campus, and this is increasingly characterising the economic force of the area. Companies in Buch are positioning themselves on international markets with molecular diagnostic processes, medical engineering devices, active treatment agents and services for research and the pharmaceutical sector. The biotechnology companies on the Berlin-Buch campus include the globally active Eckert & Ziegler Strahlen- und Medizintechnik AG, the systemic RNA-interference specialist Silence Therapeutics AG, and Glycotope GmbH, a leading technology and service provider in the fields of glycomics and immunotherapy. The biotechnology park‘s 56 companies employ 776 personnel. Buch has traditionally occupied an important position in the medical care of the residents of Berlin and Brandenburg. The HELIOS Klinikum Berlin-Buch – which has over 1,200 beds and is a maximum care hospital – and the two specialist clinics Immanuel Krankenhaus and Evangelische Lungenklinik, are today concentrated within a historic hospital area. Furthermore, the healthcare hotspot is also home to a polyclinic and numerous consultants‘ practices, which work closely together with Buch‘s hospitals. The Buch area employs a total of 6,000 staff in the healthcare sector – of which 2,900 work on the research campus and a further 3,200 on the neighbouring hospital and clinic sites, and in various other care facilities – who are committed to sustainable health. Buch, as a future-orientated location, boasts space for companies to grow and for the development of further residential developments. Attractive residential space is therefore presently under development in the historic hospital area With environmentally friendly mobility, Buch will establish itself even more strongly as the “Green Health City” in the future – in which home, work and life can be exceptionally well combined. at Clearly focussed on biomedicine, the healthcare location of Buch offers life science companies and research institutions unique conditions for synergies and added value networking. This research cooperation leads to increasingly improved and marketable processes for the diagnosis and treatment of human diseases: One of the largest biotech parks in Gerphoto: BBB Management GmbH 26 BERLIN TO GO
LOCATION THE FUTURE IS BEING MADE HERE The new CleanTech Business Park in Marzahn has everything that industrial companies in the clean technology sector require to grow photo: Bezirksamt Marzahn-Hellersdorf With the CleanTech Business Park (CBP), the largest industrial estate for clean and sustainable technologies has been estab lished in north east Berlin. The CBP is optimally aligned with the needs of production-orientated companies in the sunrise industry of clean technologies. The inner-city industrial space in the district of Marzahn-Hellersdorf, which covers 90 hectares, offers everything that companies in the segment need in order to expand – namely good transport connections, high flexibility with favourable conditions, and location factors of particular interest to industrial companies. As Berlin‘s largest continuous industrial estate, the CBP is also a designated area for companies with hazardous materials zones in accordance with the Federal Emission Control Act. This allows companies to perform almost all industrial production processes. A further advantage of the site is that the plot sizes are not fixed, and are instead individually tailored to the specific requirements of each company. This also allows companies with larger industrial facilities to settle here. The facilities offered by the CBP are aimed in particular at companies from the clean technology sectors of renewable energy and energy storage, energy efficiency, sustainable mobility, recycling and sustainable water management, raw materials and material efficiency, as well as green chemistry. Cleantech is a sunrise industry and key sector in the development of new Smart City concepts. The CBP is intended to consolidate clean technology companies on the site, to facilitate the creation of synergies through which to drive innovative solutions in the Smart City field. Suppliers and service providers to the sector can move to the 1,200 hectare “Berlin eastside” industrial estate directly neighbouring the CBP. New companies are supported by business development funding when settling here and will be integrated in local networks involving both science and industry. The CleanTech Innovation Centre (CIC) is located in the immediate vicinity of the CBP. The CIC offers economical workplace and workshop space in an inspiring environment to young companies that are focussed on clean and sustainable technologies. Focal to the CIC are production start-ups in their growth phase, which are supported in the innovation centre with an attractive mentor programme. In addition, the young companies can utilise any space on the CleanTech Business Park site that has not yet been sold for demonstration purposes. From the 2nd September, the CleanTech Business Park Marzahn was officially opened by Christian Gräff, district councillor for economy and urban development in Marzahn-Hellersdorf, and Dr. Stefan Franzke, Management Spokesperson of Berlin Partner. at The CBP site between Hohenschönhausener and Bitterfelder Straße.